News | December 11, 2025
Roche secures CE mark for groundbreaking Vaginitis test that promises accurate diagnosis
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Roche says its new assay “resolves this challenge by delivering accurate and specific results
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
Captured microbes are then neutralized on engineered microbicidal surfaces
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
